EI
ORKA

Ethic Inc’s Oruka Therapeutics ORKA Stock Holding History

Ethic Inc’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282K Buy
+2,965
New +$198K ﹤0.01% 1152

Other funds holding ORKA

SAM
Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
SAM
Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
AWM
Axxcess Wealth Management Carlsbad, California $6.28B AUM 24.26% 1-Year Est. Return

Ethic Inc's ORKA Position: Q2 2026 in Review

Ethic Inc opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 2,965 shares worth $282K. The stake represents ﹤0.01% of the portfolio and ranks #1152 among its holdings.

34 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Ethic Inc held 2,965 shares of Oruka Therapeutics worth $282K as of Q2 2026.
  • Oruka Therapeutics was a new Ethic Inc position in Q2 2026.
  • Oruka Therapeutics made up ﹤0.01% of Ethic Inc's portfolio in Q2 2026, its #1152 holding.
  • 34 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.